This patent appears to be a really unique way of expanding stem cells. Essentially the patent teaches to connect a growth factor receptor to a promoter that is only expressed on stem cells, such as the promoter for Oct-4. This way stem cells will express the growth factor receptor. This way if you add the ligand for the receptor the stem cells will proliferate...
In this patent an antibiotic resistance gene is placed under the control of a promoter associated with stem cells. This way only the stem cells will live while the other cells will die when exposed to the antibiotic.
This patent teaches ways of purifying out cells expressing myocardial genes from a heterogeneous population of stem cells. Specifically the patent teaches the use of cardiac specific promoters driving expression of markers that can be used to take the cells desired out of a heterogeneous population of cells.
This patent teaches ways of genetically modifying stem cells, and their progeny so as to generate a population of cells that is acceptable by all humanity.
This patent covers methods for identifying hematopoietic stem cells based on expression of markers such as CD34, CD38, and various growth factor receptors.
This patent covers the use of the human NT2N neurons for treatment of brain injury. Essentially, the NT2N cells are a cell line derived from a human teratocarcinoma which have neuronal properties., specifically, the cells are post-mitotic since the original teratocarcinoma cell is induced to differentiate into neurons which retinoic...
This patent teaches the extraction of hematopoietic stem cells from fetal sources. It may be that these stem cells have more potent repopulating activity as compared to stem cells from sources.
This patent covers the use of genetic markers to "fish out" stem cells from a heterogeneous population. Essentially, the patent teaches:
1. Culturing mammalian cells with a construct in which a selectable marker is turned on by a promoter which is only active in stem cells.
2. Isolating stem cells based on the selectable marker.
This is a very broad patent Inventors: Smith; Austin Gerard (Edinburgh, GB), Mountford; Peter Scott (Melbourne, AU)
This is one of the patents that teaches how to activate oocytes into parthenogenesis (ie without the male side). This patent is useful for generation of pathenogenically-derived embryonic stem cells.
This patent teaches how to make immortalized neurons through differentiation of neuronal stem cells and then transfection with various genes. These immortalized cell lines can subsequently be used for treatment of neurodegenerative conditions.